<div>Today, the U.S. Food and Drug Administration posted a new template for commercial developers to help them develop and submit emergency use authorization requests for COVID-19 diagnostic tests that can be performed entirely at home or in other settings besides a lab, such as offices or schools, and that could be available without a prescription.</div>